Premium Pyrazinamide API represents a fundamental component in modern tuberculosis treatment, manufactured to stringent international pharmacopeial standards including IP, BP, EP, ...

Premium Pyrazinamide API represents a fundamental component in modern tuberculosis treatment, manufactured to stringent international pharmacopeial standards including IP, BP, EP, and USP grades. As an FDA-approved supplier with operations dating back to 1971, we provide pharmaceutical-grade Pyrazinamide that consistently meets rigorous quality control parameters for purity, potency, and batch-to-batch consistency. Our bulk API is suitable for various dosage forms including oral tablets, capsules, and sterile injectable formulations, serving global pharmaceutical manufacturers with reliable tuberculosis treatment solutions. Each batch undergoes comprehensive testing for identity, assay, impurities, and microbial content to ensure compliance with strict regulatory requirements across international markets.

This essential antituberculosis API supports pharmaceutical companies engaged in tuberculosis treatment manufacturing across global markets. The tuberculosis therapeutic sector requires consistent, high-quality API suppliers capable of maintaining uninterrupted supply chains for both public health programs and private healthcare systems. Our Pyrazinamide is utilized by manufacturers producing combination therapies for developed and emerging markets, including WHO-prequalified products for international health initiatives. The API serves generic pharmaceutical companies, government tender suppliers, and multinational corporations addressing the global tuberculosis burden through reliable medication production and distribution networks.

Businesses selecting our Pyrazinamide API benefit from five decades of pharmaceutical manufacturing expertise and established supply chain reliability. Our FDA-approved facility and multiple pharmacopeia certifications provide assurance of consistent quality and regulatory compliance across all shipments. The ready stock availability and bulk supply capabilities ensure manufacturing continuity for client production schedules, while comprehensive documentation supports smooth regulatory submissions. This operational reliability translates to reduced production delays, consistent end-product quality, and strengthened market positioning for manufacturing partners worldwide.

Key Features:
- Manufactured to IP, BP, EP, USP, and injectable grade specifications
- FDA-approved manufacturing facility with full regulatory compliance
- Comprehensive quality control testing including HPLC, GC, and microbial analysis
- Ready stock availability for immediate shipment and production planning
- Multiple pharmacopeia certifications ensuring international standard compliance

Benefits:
- Five decades of reliable pharmaceutical manufacturing expertise
- Consistent batch-to-batch quality and purity assurance
- Reduced production delays through ready stock availability
- Global regulatory compliance supporting international market access
- Strengthened supply chain reliability for uninterrupted manufacturing